Intraday Screener (Update Freq - 1 Min)   Price/Vol, Pivots, New High    SMA / EMA    Over Bought/Sold   Tech Indicators   Candlestick
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Balance Sheet of Parabolic Drugs (PARABDRUGS)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Risk    Profitability    Qtrly Profit    Solvency    

Balance Sheet of Parabolic Drugs

Year 31_Mar_18 31_Mar_17 31_Mar_16 31_Mar_15 31_Mar_14 31_Mar_13 31_Mar_12 31_Mar_11 31_Mar_10 31_Mar_09 31_Mar_08 31_Mar_07 31_Mar_06 31_Mar_05
Book Value / Share (unadj) -140.9 -131.74 -114.28 -35.87 25.35 46.64 69.22 61.24 42.58 93.07 72.19 27.46 30.22 22.37
Capital Work In Progress 7.0 6.52 6.52 6.52 81.49 72.29 187.29 112.25 40.63 19.47 0.0 0.0 0.0 0.0
Net Block 326.0 348.84 371.19 395.13 330.75 333.54 187.89 162.96 130.26 96.82 73.58 32.64 13.52 9.23
Reserves -934.0 -877.22 -769.15 -283.96 95.03 226.76 366.52 317.11 121.37 89.3 68.37 29.16 15.57 4.95
EQ Capital Shareholdings 61.89 61.89 61.89 61.9 61.892 61.892 61.892 61.892 37.251 10.75 10.993 16.7 7.7 4.0
Working Capital -227.0 -197.55 -119.55 327.45 580.48 653.82 604.38 572.53 406.43 270.81 164.57 82.85 51.08 22.01
Shareholder's Funds -872.0 -815.33 -707.26 -222.06 156.92 288.65 428.41 379.0 158.62 100.05 79.36 45.86 23.27 8.95
Total Debt 984.0 979.47 971.75 957.49 841.94 777.14 554.72 474.41 420.69 264.03 159.42 69.66 41.33 22.29
Current Liablities 307.0 329.24 312.51 214.72 251.71 190.28 331.24 213.85 110.86 121.4 63.85 41.4 17.31 14.03
Total Liablities 1291.0 1308.71 1284.26 1172.21 1093.65 967.42 885.96 688.26 531.55 385.43 223.27 111.06 58.64 36.32
Cash & Bank Balances 0.78 0.6 0.64 3.02 5.27 12.09 34.62 25.66 17.61 13.51 7.35 3.07 2.96 2.47
Total Assets 419.0 493.38 577.0 950.14 1250.57 1256.07 1314.37 1067.26 690.17 510.48 302.63 156.92 81.91 45.27
Capital Employed 112.0 164.14 264.49 735.42 998.86 1065.79 983.13 853.41 579.31 389.08 238.78 115.52 64.6 31.24
Current Assets 80.0 131.69 192.96 542.17 832.19 844.1 935.62 786.38 517.29 392.21 228.42 124.25 68.39 36.04


Compund Annual Growth Rate (CAGR) of Parabolic Drugs

Period 1 Year 3 Year 5 Year 7 Year 10 Year
Book Value / Share 6.95 % 57.78 % 0.00 0.00 0.00
Capital WIP 7.36 % 2.40 % -37.309 % -32.726 % 0.00
Net Block -6.547 % -6.209 % -0.456 % 10.41 % 16.05 %
Reserves 6.47 % 48.72 % 0.00 0.00 0.00
EQ Capital Shareholding 0.00 -0.005 % -0.001 % -0.000 % 18.86 %
Working Capital 14.91 % 0.00 0.00 0.00 0.00
Shareholders Funds 6.95 % 57.77 % 0.00 0.00 0.00
Total Debt 0.462 % 0.915 % 4.83 % 10.98 % 19.96 %
Current Liabilities -6.755 % 12.66 % 10.04 % 5.30 % 17.00 %
Total Liabilities -1.353 % 3.27 % 5.94 % 9.40 % 19.18 %
Cash & Bank Balance 30.00 % -36.316 % -42.199 % -39.290 % -20.094 %
Total Assets -15.076 % -23.884 % -19.714 % -12.503 % 3.31 %
Capital Employed -31.766 % -46.598 % -36.275 % -25.182 % -7.291 %
Current Assets -39.251 % -47.157 % -37.578 % -27.855 % -9.960 %

Financial Data From D'Market


(All analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.